These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27358106)

  • 41. Effect of iontophoresis on topical delivery of doxorubicin-loaded solid lipid nanoparticles.
    Taveira SF; De Santana DC; Araújo LM; Marquele-Oliveira F; Nomizo A; Lopez RF
    J Biomed Nanotechnol; 2014 Jul; 10(7):1382-90. PubMed ID: 24804558
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Formulation of curcumin-loaded solid lipid nanoparticles produced by fatty acids coacervation technique.
    Chirio D; Gallarate M; Peira E; Battaglia L; Serpe L; Trotta M
    J Microencapsul; 2011; 28(6):537-48. PubMed ID: 21702702
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin.
    Li F; Sun J; Zhu H; Wen X; Lin C; Shi D
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):58-62. PubMed ID: 21764271
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cationic ligand appended nanoconstructs: a prospective strategy for brain targeting.
    Agarwal A; Agrawal H; Tiwari S; Jain S; Agrawal GP
    Int J Pharm; 2011 Dec; 421(1):189-201. PubMed ID: 21986113
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics, tissue distribution and relative bioavailability of geniposide-solid lipid nanoparticles following oral administration.
    Wang F; Cao J; Hao J; Liu K
    J Microencapsul; 2014; 31(4):382-9. PubMed ID: 24697172
    [TBL] [Abstract][Full Text] [Related]  

  • 46. pH-Dependent Adsorption Release of Doxorubicin on MamC-Biomimetic Magnetite Nanoparticles.
    García Rubia G; Peigneux A; Jabalera Y; Puerma J; Oltolina F; Elert K; Colangelo D; Gómez Morales J; Prat M; Jimenez-Lopez C
    Langmuir; 2018 Nov; 34(45):13713-13724. PubMed ID: 30394747
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Zwitterionic pH/redox nanoparticles based on dextran as drug carriers for enhancing tumor intercellular uptake of doxorubicin.
    Wu L; Zhang L; Shi G; Ni C
    Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():278-85. PubMed ID: 26838851
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation, characterization, cellular uptake and evaluation in vivo of solid lipid nanoparticles loaded with cucurbitacin B.
    Hu H; Liu D; Zhao X; Qiao M; Chen D
    Drug Dev Ind Pharm; 2013 May; 39(5):770-9. PubMed ID: 22794139
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation and cytotoxicity of 2-methoxyestradiol-loaded solid lipid nanoparticles.
    Guo X; Xing Y; Mei Q; Zhang H; Zhang Z; Cui F
    Anticancer Drugs; 2012 Feb; 23(2):185-90. PubMed ID: 22027535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy.
    Misra R; Sahoo SK
    Eur J Pharm Sci; 2010 Jan; 39(1-3):152-63. PubMed ID: 19961929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Topical Amphotericin B solid lipid nanoparticles: Design and development.
    Butani D; Yewale C; Misra A
    Colloids Surf B Biointerfaces; 2016 Mar; 139():17-24. PubMed ID: 26700229
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
    Song A; Zhang X; Li Y; Mao X; Han F
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors.
    Nafee N; Husari A; Maurer CK; Lu C; de Rossi C; Steinbach A; Hartmann RW; Lehr CM; Schneider M
    J Control Release; 2014 Oct; 192():131-40. PubMed ID: 24997276
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Doxorubicin-loaded galactose-conjugated poly(d,l-lactide-co-glycolide) nanoparticles as hepatocyte-targeting drug carrier.
    Margarida Cardoso M; Peça IN; Raposo CD; Petrova KT; Teresa Barros M; Gardner R; Bicho A
    J Microencapsul; 2016 Jun; 33(4):315-22. PubMed ID: 27189857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Delivery of retinoic acid to LNCap human prostate cancer cells using solid lipid nanoparticles.
    Akanda MH; Rai R; Slipper IJ; Chowdhry BZ; Lamprou D; Getti G; Douroumis D
    Int J Pharm; 2015 Sep; 493(1-2):161-71. PubMed ID: 26200751
    [TBL] [Abstract][Full Text] [Related]  

  • 56. N-lauroyl chitosan surface-modified PLGA nanoparticles as carrier for adriamycin to overcome cancer drug resistance.
    Li J; Zhou P; Wang Y; Chen H; Zhang C; Li R; Yang X; Wang Y
    J Microencapsul; 2014; 31(3):203-10. PubMed ID: 23937210
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Magnetic nanobeads decorated by thermo-responsive PNIPAM shell as medical platforms for the efficient delivery of doxorubicin to tumour cells.
    Deka SR; Quarta A; Di Corato R; Riedinger A; Cingolani R; Pellegrino T
    Nanoscale; 2011 Feb; 3(2):619-29. PubMed ID: 21082085
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM; Li YJ; Qiu LY; Jin Y
    J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of drug release from fibrin gels loaded with different pharmaceutical and experimental doxorubicin formulations.
    Viale M; Monticone M; Maric I; Giglio V; Profumo A; Aprile A; Cilli M; Abelmoschi ML; Rocco M
    Pharmacol Rep; 2018 Aug; 70(4):760-765. PubMed ID: 29936363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.